Page last updated: 2024-09-05

g(m1)-oligosaccharide and Lymphoma, Non-Hodgkin

g(m1)-oligosaccharide has been researched along with Lymphoma, Non-Hodgkin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Feuerstacke, Y; Götze, KS; Meyer zum Büschenfelde, C; Peschel, C; Scholze, K	1

Other Studies

1 other study(ies) available for g(m1)-oligosaccharide and Lymphoma, Non-Hodgkin

Article	Year
GM1 expression of non-Hodgkin's lymphoma determines susceptibility to rituximab treatment. Cancer research, 2008, Jul-01, Volume: 68, Issue:13 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, Neoplasm; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Immunotherapy; Lymphoma, Non-Hodgkin; Membrane Microdomains; Oligosaccharides; Prognosis; Rituximab	2008

Article

Year

GM1 expression of non-Hodgkin's lymphoma determines susceptibility to rituximab treatment.

Cancer research, 2008, Jul-01, Volume: 68, Issue:13

Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, Neoplasm; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Immunotherapy; Lymphoma, Non-Hodgkin; Membrane Microdomains; Oligosaccharides; Prognosis; Rituximab

2008